These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 9417296)

  • 21. Genetics of renal-cell carcinoma and evidence for a critical role for von Hippel-Lindau in renal tumorigenesis.
    Gnarra JR; Lerman MI; Zbar B; Linehan WM
    Semin Oncol; 1995 Feb; 22(1):3-8. PubMed ID: 7855617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biallelic inactivation of the SDHC gene in renal carcinoma associated with paraganglioma syndrome type 3.
    Malinoc A; Sullivan M; Wiech T; Schmid KW; Jilg C; Straeter J; Deger S; Hoffmann MM; Bosse A; Rasp G; Eng C; Neumann HP
    Endocr Relat Cancer; 2012 Jun; 19(3):283-90. PubMed ID: 22351710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring the hereditary background of renal cancer in Denmark.
    Christensen MB; Wadt K; Jensen UB; Lautrup CK; Bojesen A; Krogh LN; Overeem Hansen TV; Gerdes AM
    PLoS One; 2019; 14(4):e0215725. PubMed ID: 31034483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
    Kley N; Whaley J; Seizinger BR
    Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas.
    Schmidt L; Duh FM; Chen F; Kishida T; Glenn G; Choyke P; Scherer SW; Zhuang Z; Lubensky I; Dean M; Allikmets R; Chidambaram A; Bergerheim UR; Feltis JT; Casadevall C; Zamarron A; Bernues M; Richard S; Lips CJ; Walther MM; Tsui LC; Geil L; Orcutt ML; Stackhouse T; Lipan J; Slife L; Brauch H; Decker J; Niehans G; Hughson MD; Moch H; Storkel S; Lerman MI; Linehan WM; Zbar B
    Nat Genet; 1997 May; 16(1):68-73. PubMed ID: 9140397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of multiple loci on chromosome 3 in renal cell cancer development.
    van den Berg A; Buys CH
    Genes Chromosomes Cancer; 1997 Jun; 19(2):59-76. PubMed ID: 9171996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic evaluation of von Hippel-Lindau disease for early diagnosis and improved prognosis.
    Akcaglar S; Yavascaoglu I; Vuruskan H; Oktay B
    Int Urol Nephrol; 2008; 40(3):615-20. PubMed ID: 18074239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical decision-making affected by clinical and genetic screening of a novel kindred with von Hippel-Lindau disease and pancreatic islet cell tumors.
    Curley SA; Lott ST; Luca JW; Frazier ML; Killary AM
    Ann Surg; 1998 Feb; 227(2):229-35. PubMed ID: 9488521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of expression of von Hippel-Lindau tumor suppressor protein associated with improved survival in patients with early-stage clear cell renal cell carcinoma.
    Parker AS; Cheville JC; Lohse CM; Igel T; Leibovich BC; Blute ML
    Urology; 2005 Jun; 65(6):1090-5. PubMed ID: 15893810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clear cell renal cell carcinoma with wild-type von Hippel-Lindau gene: a non-existent or new tumour entity?
    Batavia AA; Schraml P; Moch H
    Histopathology; 2019 Jan; 74(1):60-67. PubMed ID: 30565303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort study.
    van Houwelingen KP; van Dijk BA; Hulsbergen-van de Kaa CA; Schouten LJ; Gorissen HJ; Schalken JA; van den Brandt PA; Oosterwijk E
    BMC Cancer; 2005 Jun; 5():57. PubMed ID: 15932632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic pathways involved in carcinogenesis of clear cell renal cell carcinoma: genomics towards personalized medicine.
    Audenet F; Yates DR; Cancel-Tassin G; Cussenot O; Rouprêt M
    BJU Int; 2012 Jun; 109(12):1864-70. PubMed ID: 22035299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of germline variants in CDH1, IGFBP3, MMP1, MMP3, STK15 and VEGF in familial and sporadic renal cell carcinoma.
    Ricketts C; Zeegers MP; Lubinski J; Maher ER
    PLoS One; 2009 Jun; 4(6):e6037. PubMed ID: 19551141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inherited forms of renal cell carcinoma.
    Kiuru M; Kujala M; Aittomäki K
    Scand J Surg; 2004; 93(2):103-11. PubMed ID: 15285561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management.
    Maher ER
    World J Urol; 2018 Dec; 36(12):1891-1898. PubMed ID: 29680948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma.
    McRonald FE; Morris MR; Gentle D; Winchester L; Baban D; Ragoussis J; Clarke NW; Brown MD; Kishida T; Yao M; Latif F; Maher ER
    Mol Cancer; 2009 Jun; 8():31. PubMed ID: 19493342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertension, antihypertensives and mutations in the Von Hippel-Lindau gene in renal cell carcinoma: results from the Netherlands Cohort Study.
    Schouten LJ; van Dijk BA; Oosterwijk E; Hulsbergen-van de Kaa CA; Kiemeney LA; Goldbohm RA; Schalken JA; van den Brandt PA
    J Hypertens; 2005 Nov; 23(11):1997-2004. PubMed ID: 16208141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial non-VHL clear cell (conventional) renal cell carcinoma: clinical features, segregation analysis, and mutation analysis of FLCN.
    Woodward ER; Ricketts C; Killick P; Gad S; Morris MR; Kavalier F; Hodgson SV; Giraud S; Bressac-de Paillerets B; Chapman C; Escudier B; Latif F; Richard S; Maher ER
    Clin Cancer Res; 2008 Sep; 14(18):5925-30. PubMed ID: 18794106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular genetics of renal cell carcinoma.
    Vignoli GC; Martorana G
    Arch Ital Urol Androl; 1997 Sep; 69(4):265-9. PubMed ID: 9396188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular genetic investigations of the mechanism of tumourigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours.
    Crossey PA; Foster K; Richards FM; Phipps ME; Latif F; Tory K; Jones MH; Bentley E; Kumar R; Lerman MI
    Hum Genet; 1994 Jan; 93(1):53-8. PubMed ID: 8270255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.